Korro Bio, Inc. Debt Instrument, Basis Spread on Variable Rate
Korro Bio, Inc. (KRRO) reported Debt Instrument, Basis Spread on Variable Rate of 9.25% for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 · last filed 2023-05-12
- Korro Bio, Inc. debt instrument, basis spread on variable rate for the quarter ending 2023-03-31 was 9.25%, a 94.74% increase year-over-year.
- Korro Bio, Inc. debt instrument, basis spread on variable rate for the quarter ending 2022-03-31 was 4.75%.
- Korro Bio, Inc. debt instrument, basis spread on variable rate for fiscal 2022 was 9.00%, a 89.47% increase from fiscal 2021.
- Korro Bio, Inc. debt instrument, basis spread on variable rate for fiscal 2021 was 4.75%.
| Period end | Debt Instrument, Basis Spread on Variable Rate 3 month | Debt Instrument, Basis Spread on Variable Rate 6 month | Debt Instrument, Basis Spread on Variable Rate 9 month | Debt Instrument, Basis Spread on Variable Rate 12 month |
|---|---|---|---|---|
| 2023-03-31 | 9.25% 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | 9.00% 10-K · filed 2023-03-10 | |||
| 2022-09-30 | 7.75% 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | 6.25% 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | 4.75% 10-Q · filed 2022-05-04 | |||
| 2021-12-31 | 4.75% 10-K · filed 2022-03-15 | |||
| 2021-09-30 | 4.75% 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |